Joseph C Galante - Net Worth and Insider Trading
Joseph C Galante Net Worth
The estimated net worth of Joseph C Galante is at least $575,414 dollars as of 2024-11-12. Joseph C Galante is the Director of Pinnacle Financial Partners Inc and owns about 4,000 shares of Pinnacle Financial Partners Inc (PNFP) stock worth over $507,160. Joseph C Galante is also the Director of Cumberland Pharmaceuticals Inc and owns about 57,356 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $68,254. Details can be seen in Joseph C Galante's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph C Galante has not made any transactions after 2023-01-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph C Galante
Joseph C Galante Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph C Galante owns 3 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) , Pinnacle Financial Partners Inc (PNFP) , and Avenue Financial Holdings Inc (AVNU) .
Click here to see the complete history of Joseph C Galante’s form 4 insider trades.
Insider Ownership Summary of Joseph C Galante
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPIX | Cumberland Pharmaceuticals Inc | 2022-12-21 | director |
| PNFP | Pinnacle Financial Partners Inc | 2023-01-20 | director |
| AVNU | Avenue Financial Holdings Inc | 2016-07-01 | director |
Joseph C Galante Latest Holdings Summary
Joseph C Galante currently owns a total of 2 stocks. Among these stocks, Joseph C Galante owns 4,000 shares of Pinnacle Financial Partners Inc (PNFP) as of January 20, 2023, with a value of $507,160 and a weighting of 88.14%. Joseph C Galante also owns 57,356 shares of Cumberland Pharmaceuticals Inc (CPIX) as of December 21, 2022, with a value of $68,254 and a weighting of 11.86%.
Latest Holdings of Joseph C Galante
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PNFP | Pinnacle Financial Partners Inc | 2023-01-20 | 4,000 | 126.79 | 507,160 |
| CPIX | Cumberland Pharmaceuticals Inc | 2022-12-21 | 57,356 | 1.19 | 68,254 |
Holding Weightings of Joseph C Galante
Joseph C Galante Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph C Galante has made a total of 4 transactions in Pinnacle Financial Partners Inc (PNFP) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Pinnacle Financial Partners Inc is the acquisition of 1,000 shares on January 20, 2023, which cost Joseph C Galante around $72,260.
According to the SEC Form 4 filings, Joseph C Galante has made a total of 15 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 15 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 1,550 shares on December 21, 2022, which cost Joseph C Galante around $3,441.
Insider Trading History of Joseph C Galante
- 1
Joseph C Galante Trading Performance
GuruFocus tracks the stock performance after each of Joseph C Galante's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph C Galante is 3.36%. GuruFocus also compares Joseph C Galante's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph C Galante within 3 months outperforms 11 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph C Galante's insider trading performs compared to the benchmark.
Performance of Joseph C Galante
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.32 | | | | | |
| Relative Return to S&P 500(%) | 0.43 | | | | | |
Joseph C Galante Ownership Network
Ownership Network List of Joseph C Galante
Ownership Network Relation of Joseph C Galante
Joseph C Galante Owned Company Details
What does Cumberland Pharmaceuticals Inc do?
Who are the key executives at Cumberland Pharmaceuticals Inc?
Joseph C Galante is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO A J Kazimi , Vice Pres Sales & Marketing Chris T. Bitterman , and Vice Pres Organizational Dev Todd M. Anthony .
Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary
Over the past 18 months, Joseph C Galante made no insider transaction in Cumberland Pharmaceuticals Inc (CPIX). Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 7,107 shares made by Kenneth Krogulski , a net purchase of 1,426 shares made by James Jones , and a net purchase of 1,426 shares made by A J Kazimi .
In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 10,672 shares, with a net purchase of 10,672 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 10,672 shares were bought by its insiders, resulting in a net purchase of 10,672 shares.
Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cumberland Pharmaceuticals Inc Insider Transactions
Joseph C Galante Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph C Galante. You might contact Joseph C Galante via mailing address: 111 Tenth Avenue, Suite 200, Nashville Tn 37203.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
